Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
The haem enzyme indoleamine 2,3-dioxygenase 1 (IDO1) catalyses the rate-limiting step in the kynurenine pathway of tryptophan metabolism and plays an essential role in immunity, neuronal function, and ageing. Expression of IDO1 in cancer cells results in the suppression of an immune response, and th...
Saved in:
Main Authors: | Ute F. Röhrig (Author), Somi Reddy Majjigapu (Author), Pierre Vogel (Author), Aline Reynaud (Author), Florence Pojer (Author), Nahzli Dilek (Author), Patrick Reichenbach (Author), Kelly Ascenção (Author), Melita Irving (Author), George Coukos (Author), Olivier Michielin (Author), Vincent Zoete (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reliable chromatographic assay for measuring of indoleamine 2,3-dioxygenase 1 (IDO1) activity in human cancer cells
by: Ilona Sadok, et al.
Published: (2021) -
Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
by: Minyan Yang, et al.
Published: (2021) -
Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation
by: Xi Xu, et al.
Published: (2019) -
Identification of the first-in-class dual inhibitors of human DNA topoisomerase IIα and indoleamine-2,3-dioxygenase 1 (IDO 1) with strong anticancer properties
by: Barbara Kaproń, et al.
Published: (2023) -
Molecular mechanisms involved in the IL-6-mediated upregulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression in the chorionic villi and decidua of women in early pregnancy
by: Rui Wang, et al.
Published: (2022)